Quantcast


Southwest Fla biotech emerges

December 7, 2009
biotech

60 people who attended a meeting this week of the Southwest Chapter of BioFlorida, an industry association in Florida since …Click Here to Read More


Is Fla. biotech sector the light at the end of the recession?

December 7, 2009
biotech

But Florida made a smart investment in establishing a vibrant biotechnology sector in our state that is now taking root. …Click Here to Read More

Burnham Researcher Awarded $8 Million Grant

December 7, 2009
biotech

LA JOLLA, Calif., September 16, 2008 — Burnham Institute for Medical Research today announced that Stuart A. Lipton, M.D., Ph.D., professor and director of the Del E. Webb Neuroscience, Aging, and Stem Cell Research Center at Burnham has been awarded $8 million, over five years, to establish a Center for Neurodegeneration Science (CNS). The center will study potential environmental causes of Parkinson’s disease. Funding for the center comes from the National Institute of Environmental Health Sciences (NIEHS) of the National Institutes of Health.

Identification of Human Factors May Yield Novel Therapeutic Targets for HIV

December 7, 2009
biotech

LA JOLLA, Calif., Oct. 2, 2008 — The Salk Institute for Biological Studies and Burnham Institute for Medical Research today announced the identification of 295 host cell factors that are involved in human immunodeficiency virus (HIV) infection. The study, published in the Oct. 3 issue of Cell, could lead to the development of a new class of HIV therapeutics aimed at disrupting the human-HIV interactions that lead to viral infection.

Burnham Researchers Turn Cancer Friend into Cancer Foe

December 7, 2009
biotech

LA JOLLA, Calif., October 7, 2008 — Burnham Institute for Medical Research today announced that scientists have created a peptide that binds to Bcl-2, a protein that protects cancer cells from programmed cell death, and converts it into a cancer cell killer. The research, which was published as the featured article in the October 7 edition of Cancer Cell, may lead to new cancer treatments.

Fishman Awards Honor Gifted, Young Burnham Researchers

December 7, 2009
biotech

LA JOLLA, Calif., October 13, 2008 — Burnham Institute for Medical Research today announced that five of the Institute’s postdoctoral research associates will be honored with Fishman Fund Awards to recognize their commitment to basic biomedical research. The awardees will receive $5,000 grants to be used to further their education and career development.

Burnham Institute for Medical Research Elects New Trustees

December 7, 2009
biotech

LA JOLLA, Calif., November 12, 2008 — Burnham Institute for Medical Research announced the election of five new members to its board of trustees. These new trustees bring a wide variety of business, legal and philanthropic experience to Burnham.

Fruit Fly Research May Lead to Better Understanding of Human Heart Disease

December 7, 2009
biotech

LA JOLLA, Calif., December 1, 2008—Researchers at the Burnham Institute for Medical Research have shown in both fruit flies and humans that genes involved in embryonic heart development are also integral to adult heart function. The study, led by Rolf Bodmer, Ph.D., was published in Proceedings of National Academy of Sciences.

Burnham Scientist Discovers Fibrosis-fighting Drug

December 7, 2009
biotech

The National Institute of Allergy and Infectious Diseases estimates that up to 45 percent of deaths in the developed world involve chronic fibrotic processes. Under a patent license from the Burnham Institute for Medical Research (Burnham) in which Burnham researcher Dr. Erkki Ruoslahti is a named inventor, Genzyme Corporation is conducting clinical trials on GC-1008, an anti-fibrotic drug.

The brains behind the Burnham Institute

December 7, 2009
biotech

ORLANDO SENTINEL, Dec. 21 — They’ve left prestigious universities and long-held research positions. Often moving across the country, a team of scientists has converged on Orlando in recent months, unpacking their test tubes and getting to work at the Burnham Institute for Medical Research.